Qiang Li1, Bin Jiao, Heather Ann Long. 1. Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. qiangli@fmmu.edu.cn
Abstract
OBJECTIVE: The aim of this study was to test the effectiveness of photodynamic therapy (PDT) in treating pseudoepitheliomatous hyperplasia (PEH) after skin wounding. BACKGROUND DATA: PEH is a difficult-to-treat extreme-degree acanthosis characterized by proliferation of the epithelium. Topical PDT offers an effective and non-invasive treatment for intraepithelial neoplasia and inflammatory dermatosis. These disorders and PEH show the same histological features: epidermal hyperplasia. To our knowledge, there have been no clinical trials published about therapeutic responses of PDT for PEH. MATERIALS AND METHODS: After application of 10-30% methyl aminolaevulinate (MAL) emulsion, each lesion was irradiated with 633-nm red light at a total dose of 113-339 J/cm(2). Therapeutic response was assessed by clinical examination at 3 months. RESULTS: Only 4 of 16 lesions clinically showed a minimal response. No response was observed in 12 of the 16 lesions, either with different cumulative doses or different concentrations of MAL. CONCLUSION: PEH after skin wounding responds poorly to the topical MAL-PDT. Besides removal of underlying diseases, surgical excision is still the recommended first option.
OBJECTIVE: The aim of this study was to test the effectiveness of photodynamic therapy (PDT) in treating pseudoepitheliomatous hyperplasia (PEH) after skin wounding. BACKGROUND DATA: PEH is a difficult-to-treat extreme-degree acanthosis characterized by proliferation of the epithelium. Topical PDT offers an effective and non-invasive treatment for intraepithelial neoplasia and inflammatory dermatosis. These disorders and PEH show the same histological features: epidermal hyperplasia. To our knowledge, there have been no clinical trials published about therapeutic responses of PDT for PEH. MATERIALS AND METHODS: After application of 10-30% methyl aminolaevulinate (MAL) emulsion, each lesion was irradiated with 633-nm red light at a total dose of 113-339 J/cm(2). Therapeutic response was assessed by clinical examination at 3 months. RESULTS: Only 4 of 16 lesions clinically showed a minimal response. No response was observed in 12 of the 16 lesions, either with different cumulative doses or different concentrations of MAL. CONCLUSION: PEH after skin wounding responds poorly to the topical MAL-PDT. Besides removal of underlying diseases, surgical excision is still the recommended first option.
Authors: R M Szeimies; S Karrer; S Radakovic-Fijan; A Tanew; P G Calzavara-Pinton; C Zane; A Sidoroff; M Hempel; J Ulrich; T Proebstle; H Meffert; M Mulder; D Salomon; H C Dittmar; J W Bauer; K Kernland; L Braathen Journal: J Am Acad Dermatol Date: 2002-08 Impact factor: 11.527
Authors: P G Calzavara-Pinton; M Venturini; R Sala; R Capezzera; G Parrinello; C Specchia; C Zane Journal: Br J Dermatol Date: 2008-07-01 Impact factor: 9.302
Authors: P Babilas; R Knobler; S Hummel; C Gottschaller; T Maisch; M Koller; M Landthaler; R-M Szeimies Journal: Br J Dermatol Date: 2007-06-02 Impact factor: 9.302
Authors: S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson Journal: Br J Cancer Date: 2003-06-02 Impact factor: 7.640